Navigation Links
Sangamo BioSciences Reports Third Quarter 2008 Financial Results
Date:10/29/2008

t encodes a ZFP

transcription factor (ZFP TF(TM)), designed to upregulate the vascular

endothelial growth factor-A (VEGF-A) gene.

* Official launch of Sigma-Aldrich CompoZr(TM) platform of zinc finger

nuclease (ZFN) reagents for gene-editing. In September, Sangamo's

partner, Sigma-Aldrich Corporation (Nasdaq: SIAL), the exclusive

distributor of ZFP products for research applications, launched sales

of CompoZr ZFN reagents. The CompoZr ZFN platform of reagents is

expected to provide researchers with the ability to target and

precisely manipulate the genome of living cells, resulting in cell

lines or whole organisms with defined gene deletions, insertions, or

corrections. Initially offered as a customized service for developing

ZFNs for specific gene targets, the CompoZr ZFN platform will

eventually include ZFN-based kits for targeted transgene insertion and

a catalog of off-the-shelf reagents for commonly studied gene targets,

gene families, and pathways. For more information on Sigma-Aldrich's

CompoZr zinc finger nuclease technology platform, visit

http://www.compozrzfn.com or contact a sales representative at

zfn@sial.com .

Conference Call

Sangamo will host a conference call today, October 29, 2008 at 5:00 p.m. ET, which will be open to the public. The call will also be webcast live and can be accessed via a link on the Sangamo BioSciences website in the Investor Relations section under "Events and Presentations" http://inve
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
3. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
4. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
5. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
6. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
7. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
8. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
9. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
10. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Nashville Fertility Center announced that ... the American Society for Reproductive Medicine (ASRM), a leading ... reproductive medicine. In his new role as treasurer, ... board and will have a voice in furthering the ... supported ASRM since 1984 when he joined while conducting ...
(Date:12/24/2014)... December 23, 2014 PharmaBoardroom,s ... out today and available for free download , digs ... change and growth in the sector today. One ... successes has been in developing a homegrown pharmaceutical manufacturing base, ... production still remains some way off. A cursory comparison with ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... 22, 2014 The American ... of original research, reviews and editorials addressing developments ... practice, today published a provocative article exploring the ... progression and potential treatment of prostate cancer. ... and proposes the possibility that there could be ...
Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... BEIJING, May 1 Sinovac Biotech Ltd. (NYSE Amex: ... in China, today announced that it has filed its Annual ... Commission for the year ended December 31, 2008 on May ... now available on the Company,s website under the investor relations ...
... of $79.7 Million, Increase of 29% over First Quarter 2008- ... per Diluted Share, Increases of 14% and 20% over First ... Therapeutics Corporation (Nasdaq: UTHR ) today announced its ... Total revenues for the first quarter of 2009 were ...
... Earnings Conference Call to be Held on May 15, ... / 8:00 pm (Beijing/Shanghai/Hong Kong)SHANGHAI, May 1 /PRNewswire-Asia/ -- ... a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... today announced that it will release financial results for ...
Cached Biology Technology:Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2United Therapeutics Reports First Quarter 2009 Financial Results 2United Therapeutics Reports First Quarter 2009 Financial Results 3United Therapeutics Reports First Quarter 2009 Financial Results 4United Therapeutics Reports First Quarter 2009 Financial Results 5United Therapeutics Reports First Quarter 2009 Financial Results 6United Therapeutics Reports First Quarter 2009 Financial Results 7WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release 2
(Date:12/19/2014)... 2014 Research and Markets ( ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... in July 2012, Apple introduced the fingerprint reading ... the only device of Apple incorporating such a ...
(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics ... easier to detect and prevent counterfeit microcircuits from ... the agency started performing an in-house microcircuit anti-counterfeit ... the authenticity of purchased microcircuits while increasing their ... control measures will be conducted at DLA,s Electronics ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "Global Facial Recognition ... http://photos.prnewswire.com/prnh/20130307/600769 ... identification of individuals. Facial recognition system measures the ... nose, jaw edges, mouth, and the distance between ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... A - a potential agent of biological warfare and one ... able to sneak into cells. , The finding is ... paralytic illness caused by the toxin more commonly known as ... alleviate many medical problems, the recent work could help to ...
... found a common genetic variation in an immune system ... psoriasis ?a disfiguring inflammatory skin disease. , Named PSORS1 ... first genetic determinant of psoriasis to be definitively identified ... to new, more effective treatments for psoriasis without the ...
... that appear to play a significant role in the ... ability to form clots following an injury. They also ... may contribute to certain forms of leukemia. , "Basically, ... are turned off in normal platelet development, but turned ...
Cached Biology News:Scientists reveal how deadly toxin hijacks cells 2U-M scientists identify major psoriasis susceptibility gene 2U-M scientists identify major psoriasis susceptibility gene 3U-M scientists identify major psoriasis susceptibility gene 4MiRNA fingerprint identified in platelet formation 2
... Source: Streptomycin verticillus USBio Analyzed PRODUCT SPECIFICATIONS Form: White powder ... pH (10 units/ml): 4.5 to 6.0 Loss On Drying: less ... equal to 0.1% Bleomycin Content: A 2 : 55 - ... B 2 : greater than or equal to 90% B ...
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
Economical and manually filled LN2 vacuum insulated storage container offers high capacity and low nitrogen consumption while offering convenient storage of samples....
... (8-iso-13,14-dihydro-15-keto PGF2α) is a metabolite of ... rabbits, monkeys and humans. 8-iso PGF2α ... lipid peroxidation. In both humans and ... primarily to metabolites having 2 or ...
Biology Products: